GlassScriptPhysician profile
Mohamad A Ali
NPI 1770758039
$2,285.92
in general payments reported to CMS, 2019-2025
16 companies · $404 in 2025
The $404 reported for 2025 was more than what 88% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $155 · 2021: $249 · 2022: $558 · 2023: $299 · 2024: $227 · 2025: $404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $930.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $929.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $811.39 | 2019-2024 | Jardiance, Ofev |
| Glaxosmithkline, LLC. | $230.82 | 2019-2023 | Nucala |
| Bayer Healthcare Pharmaceuticals INC. | $207.46 | 2022-2025 | |
| Genzyme Corporation | $144.92 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $129.81 | 2024 | Xarelto |
| Abbvie INC. | $124.66 | 2025 | |
| Orexo US, INC. | $119.98 | 2019 | |
| Phathom Pharmaceuticals, INC. | $119.70 | 2025 | Voquezna |
| Intuitive Surgical, INC. | $112.16 | 2022 | |
| Jazz Pharmaceuticals INC. | $80.30 | 2019-2020 | |
| Genentech USA, INC. | $69.65 | 2020 | |
| Novo Nordisk INC | $53.32 | 2022-2025 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $30.32 | 2024 | |
| Idorsia Pharmaceuticals US INC | $30.22 | 2023 | Quviviq |
| Emd Serono, INC. | $15.54 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5.67 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohamad Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.